Identification of miRNA-21 and miRNA-24 in plasma as potential early stage markers of acute cerebral infarction

Rink, 2011, MicroRNA in ischemic stroke etiology and pathology, Physiol Genomics, 43, 521, 10.1152/physiolgenomics.00158.2010

Laterza, 2009, Plasma MicroRNAs as sensitive and specific biomarkers of tissue injury, Clin Chem, 55, 1977, 10.1373/clinchem.2009.131797

Weng, 2011, Plasma miR-124 as a biomarker for cerebral infarction, Biomed Res, 32, 135, 10.2220/biomedres.32.135

Zeng, 2011, MicroRNA-210 as a novel blood biomarker in acute cerebral ischemia, Front Biosci (Elite Ed), 3, 1265

Tan, 2009, Expression profile of MicroRNAs in young stroke patients, PLoS One, 4, e7689, 10.1371/journal.pone.0007689

Jeyaseelan, 2008, MicroRNA expression in the blood and brain of rats subjected to transient focal ischemia by middle cerebral artery occlusion, Stroke, 39, 959, 10.1161/STROKEAHA.107.500736

Buller, 2010, MicroRNA-21 protects neurons from ischemic death, FEBS J, 277, 4299, 10.1111/j.1742-4658.2010.07818.x

Qian, 2011, miR-24 inhibits apoptosis and represses Bim in mouse cardiomyocytes, J Exp Med, 208, 549, 10.1084/jem.20101547

Siegel, 2011, miR-23a regulation of X-linked inhibitor of apoptosis (XIAP) contributes to sex differences in the response to cerebral ischemia, Proc Natl Acad Sci USA, 108, 11662, 10.1073/pnas.1102635108

Yin, 2010, miR-497 regulates neuronal death in mouse brain after transient focal cerebral ischemia, Neurobiol Dis, 38, 17, 10.1016/j.nbd.2009.12.021

Shi, 2010, MiR-21 protected human glioblastoma U87MG cells from chemotherapeutic drug temozolomide induced apoptosis by decreasing Bax/Bcl-2 ratio and caspase-3 activity, Brain Res, 1352, 255, 10.1016/j.brainres.2010.07.009

Dong, 2011, Bcl-2 upregulation induced by miR-21 via a direct interaction is associated with apoptosis and chemoresistance in MIA PaCa-2 pancreatic cancer cells, Arch Med Res, 42, 8, 10.1016/j.arcmed.2011.01.006

McDonald, 2011, Analysis of circulating microRNA: preanalytical and analytical challenges, Clin Chem, 57, 833, 10.1373/clinchem.2010.157198

Devaux, 2012, Use of circulating microRNAs to diagnose acute myocardial infarction, Clin Chem, 58, 559, 10.1373/clinchem.2011.173823

Chen, 2005, Real-time quantification of microRNAs by stem-loop RT-PCR, Nucleic Acids Res, 33, e179, 10.1093/nar/gni178

Chen, 2008, Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases, Cell Res, 18, 997, 10.1038/cr.2008.282

Yao, 2011, The altered expression of inflammation-related microRNAs with microRNA-155 expression correlates with Th17 differentiation in patients with acute coronary syndrome, Cell Mol Immunol, 8, 486, 10.1038/cmi.2011.22

Kroh, 2010, Analysis of circulating microRNA biomarkers in plasma and serum using quantitative reverse transcription-PCR (qRT-PCR), Methods, 50, 298, 10.1016/j.ymeth.2010.01.032

Fichtlscherer, 2011, Circulating microRNAs: biomarkers or mediators of cardiovascular diseases?, Arterioscler Thromb Vasc Biol, 31, 2383, 10.1161/ATVBAHA.111.226696

Lorenzen, 2012, Circulating and urinary microRNAs in kidney disease, Clin J Am Soc Nephrol, 7, 1528, 10.2215/CJN.01170212

Schwarzenbach, 2011, Cell-free nucleic acids as biomarkers in cancer patients, Nat Rev Cancer, 11, 426, 10.1038/nrc3066

Doyle, 2008, Mechanisms of ischemic brain damage, Neuropharmacology, 55, 310, 10.1016/j.neuropharm.2008.01.005

Xie, 2012, MicroRNA-24 regulates XIAP to reduce the apoptosis threshold in cancer cells, Oncogene, 32, 2442, 10.1038/onc.2012.258

Frankel, 2008, Programmed cell death 4 (PDCD4) is an important functional target of the microRNA miR-21 in breast cancer cells, J Biol Chem, 283, 1026, 10.1074/jbc.M707224200

Papagiannakopoulos, 2008, MicroRNA-21 targets a network of key tumor-suppressive pathways in glioblastoma cells, Cancer Res, 68, 8164, 10.1158/0008-5472.CAN-08-1305